Abstract
Cholangiocarcinoma is a crucial health problem in northeast Thailand. Although rare, it is a highly fatal disease and the prognosis of CCA patients is very poor. To determine if expression of specific genes is useful for diagnosis and prognosis for CCA. We examined the expression of HSP70, HSP90, RB1, cyclin D1, and HDAC6 in 50 resections of human CCA tissues by quantitative real-time PCR. The expression of HSP70, RB1, and HDAC6 was “dominant down-regulation,” while the expression of cyclin D1 and HSP90 was “dominant up-regulation.” There were no correlations between RB1, cyclin D1, HSP90, and clinicopathological parameters such as status, histology type, histological grading, stage of CCA, and metastasis. A significant association was found between HDAC6 and CCA staging (p = 0.000), CCA gross type and HSP70 (p = 0.046) as well as RB1 expression (p = 0.046). Patients with down-regulation of HSP70 had significantly poorer prognosis than those in the up-regulation group (p = 0.002). Expression of HSP70 may be useful as a new prognostic marker for CCA.
Similar content being viewed by others
Abbreviations
- CCA:
-
cholangiocarcinoma
- RB1:
-
retinoblastoma 1
- HSP70:
-
heat shock protein 70
- HSP90:
-
heat shock protein 90
- HDAC6:
-
histone deacetylase 6
References
International Agency for Research on Cancer (IARC) (1994) Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis). IARC Monogr Eval Carcinog Risks Hum 61:121–175
Sithithaworn P, Haswell-Elkins MR (2003) Epidemiology of Opisthorchis viverrini. Acta Trop 88:187–194
Sripa B, Pairojkul C (2008) Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 24:349–156
Freeman BC, Yamamoto KR (2002) Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296:2232–2235
Beere HM, Wolf BB, Cain K et al (2000) Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2:469–475
Madhavan J, Ganesh A, Kumaramanickavel G (2008) Retinoblastoma: from disease to discovery. Ophthalmic Res 40:221–226
Das SK, Hashimoto T, Shimizu K et al (2005) Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1 2. Biochim Biophys Acta 1726:328–335
Lundberg AS, Weinberg RA (1998) Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753–761
Glozak MA, Seto E (2007) Histone deacetylases and cancer. Oncogene 26:5420–5432
Hideshima T, Bradner JE, Wong J et al (2005) Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci U S A 102:8567–8572
DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762
Kondo S, Takada T, Miyazaki M et al (2008) Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg 15:41–54
Uttaravichien T, Bhudhisawasdi V, Pairojkul C et al (1999) Intrahepatic cholangiocarcinoma in Thailand. J Hepatobiliary Pancreat Surg 62:128–135
Green A, Uttaravichien T, Bhudhisawasdi V et al (1991) Cholangiocarcinoma in north east Thailand: a hospital-based study. Trop Geogr Med 43:193–198
Boonmars T, Wu Z, Boonjaruspinyo S et al (2009) Alterations of gene expression of RB pathway in Opisthorchis viverrini infection-induced cholangiocarcinoma. Parasitol Res 105:1273–1281
Liver Cancer Study Group of Japan (2003) The general rules for the clinical and pathological study of primary liver cancer, 2th ed. Tokyo: Kanehara 15
Nakanuma Y, Sripa B, Batanasapt V et al (2000) Intrahepatic cholangiocarcinoma. In: Hamilton SR, Aaltonen LA (eds) World Health Organization classification of tumours: pathology and genetics––tumours of the digestive system. IARC Press, Lyon, pp 173–180
Edge SB, Byrd DR, Compton CC et al (2009) AJCC cancer staging manual, 7th edn. Springer-Verlag Press, New York
Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86–103
Chuma M, Sakamoto M, Yamazaki K et al (2003) Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37:198–207
Lazaris AC, Chatzigianni EB, Panoussopoulos D et al (1997) Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res Treat 43:43–51
Nanbu K, Konishi I, Komatsu T et al (1996) Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Cancer 77:330–338
Abd el All H, Rey A, Duvillard P (1998) Expression of heat shock protein 70 and c-myc in cervical carcinoma. Anticancer Res 18:1533–1536
Aghdassi A, Phillips P, Dudeja V et al (2007) Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res 67:616–625
Basso AD, Solit DB, Chiosis G et al (2002) Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J Biol Chem 277:39858–39866
Vanden Berghe T, Kalai M, van Loo G et al (2003) Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis. J Biol Chem 278:5622–5629
Chen G, Cao P, Goeddel DV (2002) TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 9:401–410
Jameel A, Skilton RA, Campbell TA et al (1992) Clinical and biological significance of HSP89 alpha in human breast cancer. Int J Cancer 50:409–415
Yano M, Naito Z, Yokoyama M et al (1999) Expression of Hsp90 and cyclin D1 in human breast cancer. Cancer Lett 137:45–51
Liu X, Ye L, Wang J et al (1999) Expression of heat shock protein 90 beta in human gastric cancer tissue and SGD7901/VCR of MDR-type gastric cancer cell line. Chin Med J (Engl) 112:1133–1137
Ogata M, Naito Z, Tanaka S et al (2000) Overexpression and localization of heat shock proteins mRNA in pancreatic carcinoma. J Nippon Med Sch 67:177–185
Cardillo MR, Sale P, Di Silverio F (2000) Heat shock protein-90, IL-6 and IL-10 in bladder cancer. Anticancer Res 20:4579–4583
Bosco EE, Wang Y, Xu H et al (2007) The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. J Clin Invest 117:218–228
Contu SS, Contu PC, Damin DC et al (2007) pRB expression in esophageal mucosa of individuals at high risk for squamous cell carcinoma of the esophagus. World J Gastroenterol 13:1728–1731
Chim CS, Wong KY, Loong F et al (2007) Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma. Hum Pathol 38:1849–1857
Chatterjee SJ, Datar R, Youssefzadeh D et al (2004) Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol 22:1007–1103
Sgambato A, Migaldi M, Faraglia B et al (2002) Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome. Int J Cancer 97:671–678
Deeb KK, Michalowska AM, Yoon CY et al (2007) Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res 67:8065–8080
Kang YK, Kim WH, Jang JJ (2002) Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol 33:877–888
Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y et al (2003) Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Oncogene 22:8723–8730
Kella VK, Constantine R, Parikh NS et al (2009) Mantle cell lymphoma of the gastrointestinal tract presenting with multiple intussusceptions – case report and review of literature. World J Surg Oncol 7:60
Gillett C, Smith P, Gregory W et al (1996) Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69:92–99
Azechi H, Nishida N, Fukuda Y et al (2001) Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 60:346–354
Mitra AP, Datar RH, Cote RJ (2006) Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 24:5552–5564
Garcea G, Neal CP, Pattenden CJ et al (2005) Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 41:2213–2236
Zhang Z, Yamashita H, Toyama T et al (2004) HDAC6 expression is correlated with better survival in breast cancer. Clin Cancer Res 10:6962–6968
Acknowledgments
This work was supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission and the Thailand Research Fund through the Royal Golden Jubilee PhD program (Grant No. PHD/0139/2551) to Miss Sirintip Boonjaraspinyo and Associate Professor Thidarut Boonmars. The authors also gratefully acknowledge partial financial support from the Grant-in-Aid for Scientific Research (21590463) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We also wish to thank the Department of Parasitology, Liver Fluke and Cholangiocarcinoma Research Center, Animal Experimental Unit, Faculty of Medicine, Khon Kaen University, for their assistance. We also thank Stewart Sell, MD, Ordway Research Institute for his review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boonjaraspinyo, S., Boonmars, T., Kaewkes, S. et al. Down-Regulated Expression of HSP70 in Correlation with Clinicopathology of Cholangiocarcinoma. Pathol. Oncol. Res. 18, 227–237 (2012). https://doi.org/10.1007/s12253-011-9432-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-011-9432-5